Emgality (galcanezumab-gnlm) is a brand-name injectable solution that’s prescribed for preventing migraine attacks or treating cluster headaches in adults. The cost of the drug can depend on several ...
Emgality (fremanezumab) is a migraine medication prescribed to reduce the number and severity of migraine attacks in adults. Although no single migraine treatment works for everyone, some people have ...
INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality ® (galcanezumab-gnlm) injection (300 ...
EXTON, Pa., Sept. 11, 2019 /PRNewswire/ -- Contributing physicians appear to underestimate their use of the anti-calcitonin gene-related peptide (CGRP) therapies in patients with episodic migraine.